首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and safety of trabectedin for patients with unresectable and relapsed soft-tissue sarcoma in Japan: A Japanese Musculoskeletal Oncology Group study
Authors:Hiroshi Kobayashi MD  PhD  Shintaro Iwata MD  PhD  Toru Wakamatsu MD  PhD  Keiko Hayakawa MD  Tsukasa Yonemoto MD  PhD  Junji Wasa MD  PhD  Hiroyuki Oka MD  PhD  Takafumi Ueda MD  PhD  Sakae Tanaka MD  PhD
Affiliation:1. Department of Orthopaedic Surgery, The University of Tokyo Hospital, Tokyo, Japan;2. Division of Orthopedic Surgery, National Cancer Center Hospital, Tokyo, Japan;3. Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan;4. Department of Orthopedic Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan;5. Division of Orthopedic Surgery, Chiba Cancer Center, Chiba, Japan;6. Department of Orthopedic Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan;7. Department of Medical Research and Management for Musculoskeletal Pain, 22nd Century Medical and Research Center, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan;8. Department of Orthopedic Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan
Abstract:
Keywords:adverse drug event  rhabdomyolysis  soft-tissue sarcoma  trabectedin  treatment efficacy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号